Novozymes A/S
Major Shareholder Announcement
Novozymes A/S 09.11.2012 09:04 --------------------------------------------------------------------------- In accordance with section 29 of the Danish Securities Trading Act, Novozymes hereby announces that it has been informed that Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, has decreased its holding of B shares in Novozymes to 7.56%, previously reported at 7.64% (a decrease of 0.08%). Baillie Gifford & Co, together with its wholly owned subsidiary Baillie Gifford Overseas Limited, now holds B shares in Novozymes A/S to a total of 24,556,257 shares of a nominal value of DKK 49,112,514, equivalent to 7.56% of Novozymes A/S' share capital and 3.04% of the voting rights. The announcement is a result of Baillie Gifford Overseas Limited, a wholly owned subsidiary of Baillie Gifford & Co, increasing its holding of B shares in Novozymes A/S to a total of 16,349,463 B shares of a nominal value of DKK 32,698,926, equivalent to 5.03% of Novozymes share capital. News Source: NASDAQ OMX 09.11.2012 Dissemination of a Corporate News, transmitted by DGAP - a company of EquityStory AG. The issuer is solely responsible for the content of this announcement. DGAP's Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. Media archive at www.dgap-medientreff.de and www.dgap.de --------------------------------------------------------------------------- Language: English Company: Novozymes A/S Denmark Phone: Fax: E-mail: Internet: ISIN: DK0010272129 WKN: End of Announcement DGAP News-Service ---------------------------------------------------------------------------
Latest News
Latest Reports
No Reports found
Upcoming Events
No Events found
Webcasts
No Webcasts found